|
Quotes & Info
|
| CEMP > SEC Filings for CEMP > Form 8-K on 14-Dec-2012 | All Recent SEC Filings |
14-Dec-2012
Other Events, Financial Statements and Exhibits
On December 14, 2012, Cempra, Inc. issued a press release announcing the initiation of its Phase 2 clinical trial of CEM-102 in patients with prosthetic joint infections. A copy of this press release is attached as Exhibit 99.1.
(d) Exhibits
Exhibit
No. Description
99.1 Press release dated December 14, 2012.
|
|